Cel-Sci Corporation

AMEX: CVMHealthcare / Biotechnology / USA
6.20-0.3700-5.63%Vol 641 2991Y Perf 609.09%
Jul 22nd, 2019 16:00
BID6.23 ASK6.24
Open6.71 Previous Close6.57
Pre-Market6.64 After-Trading6.40
 0.07 1.07%  0.20 3.23%
Target Price
14.00 
Analyst Rating
Hold 3.00
Potencial %
125.81 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)209 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
65.85 
Earnings Date
13th Aug 2019

Today's Price Range

6.056.89

52wk Range

0.82008.99

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-5.20%
1 Month
-22.79%
3 Months
-6.06%
6 Months
125.45%
1 Year
609.09%
3 Years
-44.89%
5 Years
-78.80%
10 Years
-94.36%

Name / TickerPriceChg.Chg.%
CVM6.20-0.3700-5.63
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.12-0.19-58.33
Q01 2019--0.17-
Q04 2018--0.70-
Q03 2018--0.36-
Q02 2018--0.31-
Q01 2018--0.53-
Q04 2017--0.58-
Q04 2016--0.25-
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.100.00-
9/2019 QR-0.090.00-
9/2019 FY-0.47-62.07Negative
9/2020 FY-0.300.00-
Next Report Date13th Aug 2019
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume641 299
Shares Outstanding (in ths.)33 703
Trades Count1 683
Dollar Volume3 775 008
Avg. Volume731 467
Avg. Weekly Volume600 384
Avg. Monthly Volume994 066
Avg. Quarterly Volume965 851
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), an investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEO: Geert R. Kersten

Teplephone: +1 703 506-9460

Address: 8229 Boone Boulevard, Vienna 22182, VA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

63%38%

Bearish Bullish

67%33%

Bearish Bullish

62%38%

News